Adaptimmune: Audience

Adaptimmune is a clinical-stage biopharmaceutical company that develops innovative T cell therapies aimed at treating cancer and other serious diseases. Their proprietary cell therapy platform utilizes a patient's own cells to combat cancer, offering a personalized approach to treatment.